Mailroom Scanners
PRODUCTS
-
PHCbi brand’s LabSVIFT® IoT lab management solution is designed to provide real-time visibility and control of laboratory equipment and environments across single or multiple facilities. This cloud-based platform enables centralized monitoring, customizable alerts, and secure data access via a web-based dashboard. The new health check* function continuously evaluates equipment performance, identifies irregularities, and provides recommended corrective actions to maintain optimal operation. The system supports FDA 21 CFR Part 11 compliance and is compatible with select PHCbi and third-party devices. *health check function compatibility varies by model
-
The MPA3003-1 is a high-performance medium power amplifier designed for broadband linear applications in the K-Ka frequency band.
-
The QPC7333 is a voltage-controlled variable equalizer optimized for DOCSIS 4.0 upstream applications. It features a cable-compensated response and SOI attenuator for improved performance.
-
The SUI 1024-LDH2 is a second-generation, high-speed 1024-pixel linescan InGaAs camera that increases the A-line rate to 91,911 lines per second (lps).
-
Comprehensive solutions for animal heath regulatory needs.
WHITE PAPERS AND CASE STUDIES
-
Organizational Assessment For A Large MedTech Company
Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.
-
RO Membranes' Protection At Pinghu Power Plant, China
A power plant in Pinghu, Zhejiang Province in China needed to replace the use of chemical biocides and protect boiler feed make-up water from anaerobic and aerobic bacterial growth and associated biofouling.
-
Simplify CAPA In 7 Steps
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Breaking Barriers In Malaria Prevention With A Mobile Cleanroom
The delivery of this mobile cGMP cleanroom facility to ACT showcases Germfree’s commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.
-
Generation Of A Contamination Control Strategy
An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.
-
Drinking Water Disinfection In A New Hampshire Town
The town of Hillsborough, NH chose Atlantium's HOD UV system to disinfect their drinking water due to its low disinfection by-products and reliable virus inactivation. Atlantium's UV technology is validated and offers stable and efficient water treatment solutions.
-
Performance Of HEKima™ Adherent HEK Cell Medium
Explore the performance of a serum-free medium designed for HEK-293 cells, comparing its efficacy to traditional media for protein expression and cell proliferation.
-
Owen Mumford Slashes Audit Findings, CAPAs, And NCRs
Gain insights into how Owen Mumford, a global medical device leader, enhanced their compliance and efficiency with software to reduce audit findings and improve quality management.
-
Low Capacitance SWIR Photodetectors For High Speed Sensing Applications
Sensors Unlimited Inc. developed high-speed SWIR focal plane arrays with reduced capacitance for improved LiDAR performance, enhancing laser pulse detection, low-light imaging, and laser range-finding applications.
-
Vibration Compensated OCXOs: Advantages, Disadvantages, And Market Applications
Electronically compensated and mechanically isolated OCXOs each offer unique benefits for vibration-sensitive applications; choosing the right design depends on size, power, and performance requirements.
-
Streamlining Clinical Trial Start-Up In Australia
Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.
-
Rapid Startup Phase 1 Cardiomyopathy CRISPR Gene Therapy
Hereditary transthyretin amyloidosis (ATTRv) is very rare, prompting a Phase 1 trial of in vivo CRISPR/Cas9 gene editing to reduce mutant protein and stop cardiomyopathy progression.
NEWS
-
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007, An Antibody Drug Conjugate For The Treatment Of Gastrointestinal Cancers1/21/2025
ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it has entered into an exclusive license agreement with Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers.
-
Ericsson Unveils New Wave Of Radio, Antenna, And RAN Connect Products To Advance High-Performing Programmable Networks2/12/2025
As telecoms industry engagement with high-performing programmable networks ramps up globally, Ericsson is meeting related future needs through a significant product portfolio boost.
-
API Releases Bulletin Demonstrating The Suitability Of Portland Cement For CCUS Projects11/6/2025
The American Petroleum Institute (API) today announced the publication of API Bulletin 5100, Ordinary Portland Cement as a Barrier for Carbon Capture, Utilization, and Storage (CCUS) Applications.
-
Simbe Expands Next-Generation Computer Vision Technology To Transform Retail Execution5/20/2025
Simbe, the global leader in shelf digitization, today announced significant advancements to Simbe Vision™, its AI-powered computer vision (CV) technology, further solidifying the company's position as the retail industry's most advanced in-store intelligence solution.